NO932874D0 - Anvendelse av lacidipin for behandling av arteriosklerose - Google Patents

Anvendelse av lacidipin for behandling av arteriosklerose

Info

Publication number: NO932874D0
Authority: NO; Norway
Prior art keywords: treatment; scerosis; arteryos; lacidipin; application
Prior art date: 1991-02-13

Application number

NO1993932874A

Other languages

English (en)

Other versions

NO303713B1 (no

NO932874L (no

Inventor

Giovanni Gaviraghi

Original Assignee

Glaxo Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-02-13

Filing date

1993-08-12

Publication date

1993-08-12

1993-08-12 Application filed by Glaxo Spa filed Critical Glaxo Spa

1993-08-12 Publication of NO932874D0 publication Critical patent/NO932874D0/no

1993-08-12 Publication of NO932874L publication Critical patent/NO932874L/no

1998-08-24 Publication of NO303713B1 publication Critical patent/NO303713B1/no

Links

VGUWZCUCNQXGBU-UHFFFAOYSA-N 3-[(4-methylpiperazin-1-yl)methyl]-5-nitro-1h-indole Chemical compound C1CN(C)CCN1CC1=CNC2=CC=C([N+]([O-])=O)C=C12 VGUWZCUCNQXGBU-UHFFFAOYSA-N 0.000 abstract 1
206010003210 Arteriosclerosis Diseases 0.000 abstract 1
208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
GKQPCPXONLDCMU-CCEZHUSRSA-N lacidipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1C1=CC=CC=C1\C=C\C(=O)OC(C)(C)C GKQPCPXONLDCMU-CCEZHUSRSA-N 0.000 abstract 1
229960004340 lacidipine Drugs 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO932874A 1991-02-13 1993-08-12 Anvendelse av lacidipin for behandling av arteriosklerose NO303713B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ITMI910359A IT1244728B (it)	1991-02-13	1991-02-13	Impiego medicamentoso di derivati diidropiridinici
PCT/EP1992/000276 WO1992014460A1 (en)	1991-02-13	1992-02-08	Use of lacidipine for the treatment of arteriosclerosis

Publications (3)

Publication Number	Publication Date
NO932874D0 true NO932874D0 (no)	1993-08-12
NO932874L NO932874L (no)	1993-08-12
NO303713B1 NO303713B1 (no)	1998-08-24

Family

ID=11358541

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO932874A NO303713B1 (no)	1991-02-13	1993-08-12	Anvendelse av lacidipin for behandling av arteriosklerose

Country Status (23)

Country	Link
US (1)	US5455257A (no)
EP (2)	EP0576433A1 (no)
JP (1)	JP2996725B2 (no)
KR (1)	KR100188171B1 (no)
AT (1)	ATE157004T1 (no)
AU (1)	AU646929B2 (no)
CA (1)	CA2103805C (no)
CZ (1)	CZ281760B6 (no)
DE (1)	DE69221649T2 (no)
DK (1)	DK0499920T3 (no)
ES (1)	ES2106098T3 (no)
GR (1)	GR3024661T3 (no)
IE (1)	IE920453A1 (no)
IL (1)	IL100928A (no)
IT (1)	IT1244728B (no)
MX (1)	MX9200600A (no)
NO (1)	NO303713B1 (no)
PH (1)	PH30130A (no)
RU (1)	RU2136279C1 (no)
SG (1)	SG59972A1 (no)
UA (1)	UA27780C2 (no)
WO (1)	WO1992014460A1 (no)
ZA (1)	ZA921006B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69627137T2 (de) *	1995-06-07	2003-12-04	Ivax Research, Inc.	Verwendung von pentosan polysulfat zur behandlung von narben in chronischer fortschreitender gefässerkrankungen
RU2287327C2 (ru) *	2003-10-16	2006-11-20	Юрий Антонович Кошелев	Средство для лечения и профилактики атеросклероза
EP1868577A4 (en) *	2005-04-15	2009-12-09	Reddys Lab Inc Dr	Lacidipine PARTICLE
WO2007096694A1 (es) *	2006-02-22	2007-08-30	Ramiro Vergara	Asociacion de principios activos neuroactivadores

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS597163A (ja) *	1982-07-02	1984-01-14	Yamanouchi Pharmaceut Co Ltd	抗動脈硬化剤
NZ212895A (en) *	1984-08-22	1988-07-28	Glaxo Spa	1,4-dihydropyridine derivatives and pharmaceutical compositions
GB8431119D0 (en) *	1984-12-10	1985-01-16	Fujisawa Pharmaceutical Co	Anti-arteriosclerotic composition

1991
- 1991-02-13 IT ITMI910359A patent/IT1244728B/it active IP Right Grant
1992
- 1992-02-08 AT AT92102146T patent/ATE157004T1/de not_active IP Right Cessation
- 1992-02-08 US US08/094,150 patent/US5455257A/en not_active Expired - Lifetime
- 1992-02-08 DK DK92102146.5T patent/DK0499920T3/da active
- 1992-02-08 RU RU93054780A patent/RU2136279C1/ru active
- 1992-02-08 ES ES92102146T patent/ES2106098T3/es not_active Expired - Lifetime
- 1992-02-08 JP JP4503957A patent/JP2996725B2/ja not_active Expired - Fee Related
- 1992-02-08 EP EP92903946A patent/EP0576433A1/en not_active Withdrawn
- 1992-02-08 EP EP92102146A patent/EP0499920B1/en not_active Expired - Lifetime
- 1992-02-08 CZ CS931650A patent/CZ281760B6/cs not_active IP Right Cessation
- 1992-02-08 CA CA002103805A patent/CA2103805C/en not_active Expired - Fee Related
- 1992-02-08 UA UA93004263A patent/UA27780C2/uk unknown
- 1992-02-08 SG SG1996007490A patent/SG59972A1/en unknown
- 1992-02-08 AU AU12231/92A patent/AU646929B2/en not_active Ceased
- 1992-02-08 DE DE69221649T patent/DE69221649T2/de not_active Expired - Fee Related
- 1992-02-08 WO PCT/EP1992/000276 patent/WO1992014460A1/en not_active Ceased
- 1992-02-12 IE IE045392A patent/IE920453A1/en not_active IP Right Cessation
- 1992-02-12 ZA ZA921006A patent/ZA921006B/xx unknown
- 1992-02-12 PH PH43915A patent/PH30130A/en unknown
- 1992-02-12 IL IL10092892A patent/IL100928A/xx not_active IP Right Cessation
- 1992-02-12 MX MX9200600A patent/MX9200600A/es unknown
1993
- 1993-08-12 KR KR1019930702402A patent/KR100188171B1/ko not_active Expired - Fee Related
- 1993-08-12 NO NO932874A patent/NO303713B1/no not_active IP Right Cessation
1997
- 1997-09-09 GR GR970402303T patent/GR3024661T3/el unknown

Also Published As

Publication number	Publication date
UA27780C2 (uk)	2000-10-16
EP0576433A1 (en)	1994-01-05
CA2103805A1 (en)	1992-08-14
CZ281760B6 (cs)	1997-01-15
WO1992014460A1 (en)	1992-09-03
CZ165093A3 (en)	1994-03-16
DE69221649D1 (de)	1997-09-25
PH30130A (en)	1997-01-21
MX9200600A (es)	1992-10-30
AU1223192A (en)	1992-09-15
JP2996725B2 (ja)	2000-01-11
IT1244728B (it)	1994-08-08
SG59972A1 (en)	1999-02-22
DE69221649T2 (de)	1997-12-11
JPH06505002A (ja)	1994-06-09
ITMI910359A1 (it)	1992-08-13
EP0499920A1 (en)	1992-08-26
ES2106098T3 (es)	1997-11-01
NO303713B1 (no)	1998-08-24
IL100928A (en)	1997-02-18
EP0499920B1 (en)	1997-08-20
NO932874L (no)	1993-08-12
ZA921006B (en)	1992-12-30
RU2136279C1 (ru)	1999-09-10
ITMI910359A0 (it)	1991-02-13
GR3024661T3 (en)	1997-12-31
CA2103805C (en)	2002-09-17
HK1009585A1 (en)	1999-06-04
DK0499920T3 (da)	1998-01-26
US5455257A (en)	1995-10-03
AU646929B2 (en)	1994-03-10
ATE157004T1 (de)	1997-09-15
KR100188171B1 (en)	1999-06-01
IE920453A1 (en)	1992-08-12

Similar Documents

Publication	Publication Date	Title
DE69620306D1 (de)	2002-05-08	4-(.Alpha.-hydroxy-.alpha.-aryl-alkylcarbonylamino)-Piperidine zur Behandlung und Prophylaxe von Erkrankungen der Harnwege
DK0393911T3 (da)	1994-10-03	Fungicide oxazolidinoner
ATE253361T1 (de)	2003-11-15	Mittel zur gesteuerten freisetzung von paroxetin
ATE121295T1 (de)	1995-05-15	Augentropfenarzneimittel.
DE69300062D1 (de)	1995-03-23	Verfahren zur Herstellung von N-Methoxyderivate von 4-Hydroxy-2,2,6,6-Tetramethylpiperidin und 2,2,6,6-Tetramethyl-4-Piperidon.
HUP9900927A3 (en)	2002-02-28	Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
FI964566L (fi)	1996-11-14	Menetelmä ja diastereomeerisia suoloja, jotka ovat käyttökelpoisia raseemisen alfa-(4-(1,1-dimetyletyl)fenyl)-4-(hydroksidifenyyli-metyyli)-1-piperidiinibutanolin ja sen johdosyhdisteiden optisessa resoluutiossa
NO932874L (no)	1993-08-12	Anvendelse av lacidipin for behandling av arteriosklerose
PT790236E (pt)	2004-04-30	Pro-farmacos de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil-6-cloro-1,3-di-hidro-2h-indol-2-ona
RU93054780A (ru)	1996-10-10	Применение лацидипина для лечения артериосклероза
EE04235B1 (et)	2004-02-16	Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks
DE69231883D1 (de)	2001-07-26	4-(1,1-Dialkoxycarbonyl-Alkyl)Azetidin-2-on-Derivate zur Herstellung von 4-(1-Carboxy-Alkyl)Azetidin-2-on-Derivaten
DE59310153D1 (de)	2001-04-12	Verfahren zur Herstellung von 4-Hydroxy-2.2.6.6-tetramethylpiperidin
DE69625069D1 (de)	2003-01-09	Insektizide von n-(substituiertes arylmethyl)-4-(bis (substituiertes phenyl oder pyridyl)methyl)-piperidin.
NO953322D0 (no)	1995-08-24	Anvendelse av 1,4-dihydropyridin-3,5-dikarboksylsyreestere som legemidler
ITRM910211A0 (it)	1991-03-29	Impianto dentale endosseo.
ATE122352T1 (de)	1995-05-15	3-(3-ethyl-1,2,4-oxadiazol-5-yl)-1- azabicycloheptan, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen.
NO178093C (no)	1996-01-24	Anordning for bedring av miljö i munnhulen ved tannbehandling
EP0800393A4 (en)	1998-05-06	MONOMERS OF 4.4- (DISUBSTITUTED) CYCLOHEXAN-1-ONE AND COMPOUNDS THEREOF
DZ1831A1 (fr)	2002-02-17	Isopropyl 2-méthoxyéthyl 4-(2-chloro-3-cyano-phényl)-1,4-dihydro 2,6-diméthyl-pyridine 3,5-dicarboxylate.
NO985558D0 (no)	1998-11-27	Ny forbedret formulering for behandling av tromboembolisme
DE69616484D1 (de)	2001-12-06	Verwendung vom 3-Alpha-Hydroxy-5Alpha-Androsta-16-ene als Arzneimittel
EP0799183A4 (en)	1998-03-25	MONOMERS OF 3.3- (DISUBSTITUTED) CYCLOHEXAN-1-ONE AND RELATED COMPOUNDS
DE59407086D1 (de)	1998-11-19	Verfahren zur Herstellung von 3-(p-Fluorphenyl)-2-methylpropionsäure und 3-(p-Fluorphenyl)-2-methylpropionsäurederivaten
DE69200943D1 (de)	1995-02-02	Derivate von Piperidin.

Legal Events

Date	Code	Title	Description
2010-09-27	MM1K	Lapsed by not paying the annual fees